These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1304 related articles for article (PubMed ID: 26297431)

  • 21. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
    Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
    Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
    Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
    Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
    Ko H
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celastrol inhibits TGF-β1-induced epithelial-mesenchymal transition by inhibiting Snail and regulating E-cadherin expression.
    Kang H; Lee M; Jang SW
    Biochem Biophys Res Commun; 2013 Aug; 437(4):550-6. PubMed ID: 23850675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
    Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
    Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
    Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
    Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
    Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
    J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
    Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
    Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.
    Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG
    Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR‑192, a Smad3-dependent microRNA.
    Hong JP; Li XM; Li MX; Zheng FL
    Int J Mol Med; 2013 Jun; 31(6):1436-42. PubMed ID: 23588932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel TGF-β1 inhibitor antagonizes TGF-β1-induced epithelial-mesenchymal transition in human A549 lung cancer cells.
    Jeong JH; Jang HJ; Kwak S; Sung GJ; Park SH; Song JH; Kim H; Na Y; Choi KC
    J Cell Biochem; 2019 Jan; 120(1):977-987. PubMed ID: 30216515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous hydrogen sulfide donor NaHS alleviates nickel-induced epithelial-mesenchymal transition and the migration of A549 cells by regulating TGF-β1/Smad2/Smad3 signaling.
    Ye M; Yu M; Yang D; Li J; Wang H; Chen F; Yu H; Shen T; Zhu Q; Zhou C
    Ecotoxicol Environ Saf; 2020 Jun; 195():110464. PubMed ID: 32171946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.
    Velden JL; Alcorn JF; Guala AS; Badura EC; Janssen-Heininger YM
    Am J Respir Cell Mol Biol; 2011 Apr; 44(4):571-81. PubMed ID: 20581097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.
    Feng H; Lu JJ; Wang Y; Pei L; Chen X
    Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nannocystin Ax, a natural elongation factor 1α inhibitor from Nannocystis sp., suppresses epithelial-mesenchymal transition, adhesion and migration in lung cancer cells.
    Sun C; Liu R; Xia M; Hou Y; Wang X; Lu JJ; Liu B; Chen X
    Toxicol Appl Pharmacol; 2021 Jun; 420():115535. PubMed ID: 33848516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokeratin 18 is necessary for initiation of TGF-β1-induced epithelial-mesenchymal transition in breast epithelial cells.
    Jung H; Kim B; Moon BI; Oh ES
    Mol Cell Biochem; 2016 Dec; 423(1-2):21-28. PubMed ID: 27734227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
    Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
    Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.